Bruce R. Schackman

The Survival Benefits of AIDS Treatment in the United States

Rochelle P. Walensky, A. David Paltiel, Elena Losina et al. · The Journal of Infectious Diseases · 2006 · 581 citations

Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection

Roy M. Gulick, Heather J. Ribaudo, Cecilia M. Shikuma et al. · New England Journal of Medicine · 2004 · 526 citations · Full text

Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population

Jake R. Morgan, Bruce R. Schackman, Jared A. Leff et al. · Journal of Substance Abuse Treatment · 2017 · 325 citations · Full text

Substance Use Disorders, Oral Naltrexone, Substance Abuse +15

Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians

Yuhua Bao, Yijun Pan, Aryn Taylor et al. · Health Affairs · 2016 · 321 citations · Full text

HIV Preexposure Prophylaxis in the United States: Impact on Lifetime Infection Risk, Clinical Outcomes, and Cost‐Effectiveness

A. David Paltiel, Kenneth A. Freedberg, Callie A. Scott et al. · Clinical Infectious Diseases · 2009 · 268 citations · Full text